An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

Clinical trial NCT05369832 · TERMINATED

Trial details

NCT number: NCT05369832
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2022-12-16
Primary completion: 2025-01-21
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.